INMUNE BIO INC. Deferred Tax Assets, Operating Loss Carryforwards
INMUNE BIO INC. (INMB) had Deferred Tax Assets, Operating Loss Carryforwards of $8.69 million as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-03-27
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $8.69M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.85M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.44M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.70M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2024-12-31 | $8.69M 10-K · filed 2025-03-27 |
| 2023-12-31 | $6.85M 10-K · filed 2025-03-27 |
| 2022-12-31 | $5.44M 10-K · filed 2024-03-28 |
| 2021-12-31 | $3.70M 10-K · filed 2023-03-02 |
| 2020-12-31 | $2.20M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |